AstraZeneca (AZNCF) News Today $127.96 -2.28 (-1.75%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartDividendFinancialsHeadlinesOwnershipSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period AstraZeneca Director Bolsters Stake with Share PurchaseNovember 14 at 1:41 AM | markets.businessinsider.comAstraZeneca: Strong Q3 Growth and Strategic Moves Justify Buy RatingNovember 14 at 1:41 AM | markets.businessinsider.comAstraZeneca’s Koselugo Expands Potential in Adult TreatmentNovember 13, 2024 | markets.businessinsider.comMerck and AstraZeneca announce results of Koselugo in neurofibromatosis trialNovember 12, 2024 | markets.businessinsider.comAstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It Takes China Investigations 'Very Seriously'November 12, 2024 | finance.yahoo.comAstraZeneca to fully cooperate with Chinese authorities if requestedNovember 12, 2024 | markets.businessinsider.comAstraZeneca Q3 Earnings Preview: Will Cancer, Heart Drugs Fuel Continued Growth?November 11, 2024 | benzinga.comPharma Giant AstraZeneca Says China Chief DetainedNovember 8, 2024 | barrons.comAstraZeneca (AZN) Gets a Sell from Deutsche BankNovember 5, 2024 | markets.businessinsider.comAstraZeneca’s Promising Obesity Treatment Advances Justify Buy Rating: Analyst ReportNovember 5, 2024 | markets.businessinsider.comAstraZeneca fraud investigation expands in ChinaNovember 5, 2024 | msn.comAstraZeneca's Obesity Pills Revealed Positive Result In Phase I TrialsNovember 5, 2024 | finance.yahoo.comPharma giant AstraZeneca says its China chief is under investigationNovember 1, 2024 | msn.comAstraZeneca Announces Share Capital DetailsNovember 1, 2024 | markets.businessinsider.comPharma Giant AstraZeneca Says China Chief Under InvestigationOctober 31, 2024 | barrons.comFirstFT: AstraZeneca China president under investigationOctober 30, 2024 | ft.comAstraZeneca pleased as EU approves Fasenra for treatment of EGPAOctober 29, 2024 | lse.co.ukJ.P. Morgan Remains a Buy on AstraZeneca (AZN)October 26, 2024 | markets.businessinsider.comChina Detains Ex-AstraZeneca Executive in Sign of Widening ProbeOctober 25, 2024 | bloomberg.comAstraZeneca polyneuropathy treatment recommended for EU approvalOctober 21, 2024 | lse.co.ukAs AstraZeneca’s share price drops 11%, does the stock look an unmissable bargain to me?October 21, 2024 | fool.co.ukAstraZeneca remains steady Thursday, underperforms marketOctober 17, 2024 | marketwatch.comIs AstraZeneca PLC (AZN) the Best High Growth NASDAQ Stock That is Profitable in 2024?October 16, 2024 | insidermonkey.comAstraZeneca’s Phase III trial of treatment for asthma meets its primary endpointOctober 8, 2024 | finance.yahoo.comOwkin partners with AstraZeneca to enhance gBRCA testing for breast cancerOctober 4, 2024 | msn.comOwkin and AstraZeneca to develop AI tool for breast cancer testingOctober 3, 2024 | finance.yahoo.comAstraZeneca (AZN): A Strong Buy as FDA Approves Key Cancer Treatments and Revenue SurgesSeptember 30, 2024 | msn.comImmunai, AstraZeneca collaborate to optimize cancer clinical trialsSeptember 26, 2024 | msn.comIsraeli AI startup forges $18m partnership with AstraZeneca for cancer drug trialsSeptember 26, 2024 | msn.comAstraZeneca Stock Dips On Surprise Miss For Gilead-Rivaling Cancer DrugSeptember 24, 2024 | msn.comAstraZeneca, Daiichi’s Enhertu successor faces more questions after latest stumbleSeptember 23, 2024 | finance.yahoo.comAstraZeneca's experimental drug disappoints in breast cancer survival trialSeptember 23, 2024 | msn.comAstraZeneca and Daiichi Sankyo report data from Phase III breast cancer trialSeptember 23, 2024 | finance.yahoo.comTOP NEWS: AstraZeneca cancer drug fails to significantly extend livesSeptember 23, 2024 | lse.co.ukAstraZeneca drug fails to extend lives of breast cancer patients significantlySeptember 23, 2024 | ft.comUS FDA approves AstraZeneca's self-administered nasal spray flu vaccineSeptember 20, 2024 | msn.comAstraZeneca's FluMist nasal spray vaccine approved for self-administrationSeptember 20, 2024 | msn.comAstraZeneca: Poised for Growth with Promising Innovation Pipeline and Attractive ValuationSeptember 20, 2024 | markets.businessinsider.comAstraZeneca (LSE:AZN) Gains FDA Approval for Fasenra in EGPA, Boosting Revenue Growth and Market PositionSeptember 20, 2024 | finance.yahoo.comPfizer and AstraZeneca debate: when “the greater good” mattersSeptember 19, 2024 | msn.comAstraZeneca’s Imfinzi and Imjudo found to extend survival in liver cancer trialSeptember 17, 2024 | finance.yahoo.comHealthy 27-year-old died after NHS wrongly gave him AstraZeneca Covid jabSeptember 17, 2024 | yahoo.comAstraZeneca and MSD hail progress in hard-to-treat cancersSeptember 17, 2024 | ft.comSanofi, AstraZeneca win US approval for RSV therapy manufacturing lineSeptember 16, 2024 | msn.com5 Oversold Stocks to Buy Right Now (AZNCF)We've got you covered with a list of oversold stocks to buy right now. Learn more about oversold and overbought stocks on MarketBeat.September 16, 2024 | marketbeat.comTOP NEWS: AstraZeneca celebrates survival rate of Imfinzi-Imjudo mixSeptember 16, 2024 | lse.co.ukUBS Sticks to Its Sell Rating for AstraZeneca (AZN)September 16, 2024 | markets.businessinsider.comAstraZeneca Shares Set For Worst Week in 14 Months on Sell CallsSeptember 13, 2024 | bloomberg.comAstraZeneca PLC ADR underperforms Thursday when compared to competitorsSeptember 12, 2024 | marketwatch.comKepler Capital Sticks to Their Hold Rating for AstraZeneca (AZN)September 12, 2024 | markets.businessinsider.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZNCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Strange: Why is Amazon suddenly yielding 39.70%? (Ad)Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%! Click here to see this breakthrough before everyone else → AZNCF Media Mentions By Week AZNCF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZNCF News Sentiment▼0.190.56▲Average Medical News Sentiment AZNCF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZNCF Articles This Week▼86▲AZNCF Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZNCF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies 4Front Ventures News Today Algernon Pharmaceuticals News Today Allstar Health Brands News Today Alvotech News Today American Premium Mining News Today Anew Medical News Today Arno Therapeutics News Today AVVAA World Health Care Products News Today Basilea Pharmaceutica News Today biote News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AZNCF) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZNCF Stock Alerts